Syncom Formulations (India) Ltd. Hits Upper Circuit on BSE, 29 September 2026

On 29 September 2026, Syncom Formulations (India) Ltd. (SYNCOMF) hit the upper circuit on BSE at Rs 26.64, a 20% positive move from the previous close of Rs 22.2. The company’s market cap stood at Rs 2086.8 crore. The upper circuit price for the session was Rs 26.64.

The move was driven by buying interest against the exchange-defined price band. At the time of writing the stock was locked at its upper circuit level, which makes the session worth noting for short-term market participants.

Key Takeaways

• Syncom Formulations (India) Ltd. (SYNCOMF) hit the upper circuit on BSE at Rs 26.64 on 29 September 2026.
• The session move was +20% against a previous close of Rs 22.2.
• Market capitalisation stood at Rs 2086.8 crore with a PE ratio of 24.4.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

All figures above are as of 29 September 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Syncom Formulations (India) Ltd. opened at Rs 22.36 on BSE, compared with a previous close of Rs 22.2. During the session, the stock traded between Rs 22.06 and Rs 26.64 before touching the upper circuit price of Rs 26.64.

The absolute day change was Rs 4.44, while the percentage move was 20%. The event figures are kept to a single exchange so the numbers stay comparable.

The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses BSE consistently for the event table and narrative. The stated upper circuit limit for the session was Rs 26.64, which is the level the price reached.

Why Syncom Formulations (India) Ltd. Hit Upper Circuit

Syncom Formulations (India) Ltd. hit the upper circuit after buying interest pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the upper circuit level of Rs 26.64.

What the Upper Circuit Means

An upper circuit is the maximum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Syncom Formulations (India) Ltd., the captured upper circuit price was Rs 26.64 on 29 September 2026.

The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the upper circuit explains what happened in the session and where the price band was reached.

Syncom Formulations (India) Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Syncom Formulations (India) Ltd., PE ratio was 24.4, PB ratio was 4.74, book value was Rs 4.68, EPS was 0.91, ROE was 20.19%, ROCE was 26.8%, dividend yield was 0.45% and debt-to-assets ratio was 0, on a market cap of Rs 2086.8 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 4.74, the market valued Syncom Formulations (India) Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking upper circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Syncom Formulations (India) Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Syncom Formulations (India) Ltd.’s PE ratio was 24.4, compared with an available peer PE average of 172.16, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 60.28, the 50-day moving average was 18.46 and the 200-day moving average was 14.72.

What Readers Should Know

The main confirmed fact is that Syncom Formulations (India) Ltd. hit the upper circuit on BSE at Rs 26.64 on 29 September 2026, with a 20% day move.

The practical limitation after an upper-circuit session is execution. Buyers queue at the band and sellers step back, so the quoted price is not necessarily a price you can transact at. The other limitation is that no official catalyst was confirmed at the time of writing.

Readers should treat upper circuit events as market updates, not standalone investment conclusions. The price band shows strong near-term interest, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.

Frequently Asked Questions

Why did Syncom Formulations (India) Ltd. hit upper circuit on 29 September 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was SYNCOMF share price on 29 September 2026?

The last traded price used in this article was Rs 26.64 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for SYNCOMF?

The upper circuit price was Rs 26.64. The stated exchange upper circuit limit was Rs 26.64. The event numbers in this article are aligned to BSE.

What is Syncom Formulations (India) Ltd.’s market cap and PE ratio?

Syncom Formulations (India) Ltd.’s market cap was Rs 2086.8 crore. PE ratio was 24.4.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 29 September 2026.

Does hitting an upper circuit mean Syncom Formulations (India) Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Syncom Formulations (India) Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Syncom Formulations (India) Ltd. the stated limit was Rs 26.64. For this session, Syncom Formulations (India) Ltd. moved 20%.